Terms: = Lymphoma AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Treatment
61 results:
1. Successful Kidney and Hematopoietic Stem Cell Transplantation for Malignant lymphoma from Different Donors: A Case Report and Literature Review.
Ono K; Ishibashi Y; Kaname S
Transplant Proc; 2022; 54(6):1589-1593. PubMed ID: 35840432
[TBL] [Abstract] [Full Text] [Related]
2. A retrospective study on the clinicopathological and molecular features of 22 cases of natural killer/T-cell lymphoma in children and adolescents.
Wang GN; Zhao WG; Zhang XD; Jian XY; Zhang CL; Zhang MZ; Li WC
Sci Rep; 2022 May; 12(1):7118. PubMed ID: 35504960
[TBL] [Abstract] [Full Text] [Related]
3. Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma.
Carvajal RD; Nathan P; Sacco JJ; Orloff M; Hernandez-Aya LF; Yang J; Luke JJ; Butler MO; Stanhope S; Collins L; McAlpine C; Holland C; Abdullah SE; Sato T
J Clin Oncol; 2022 Jun; 40(17):1939-1948. PubMed ID: 35254876
[TBL] [Abstract] [Full Text] [Related]
4.
Jahantigh HR; Stufano A; Lovreglio P; Rezaee SA; Ahmadi K
J Biomol Struct Dyn; 2022 Sep; 40(15):6737-6754. PubMed ID: 33648421
[TBL] [Abstract] [Full Text] [Related]
5. Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression.
Wen L; Zou X; Chen Y; Bai X; Liang T
Front Immunol; 2020; 11():2076. PubMed ID: 32973816
[TBL] [Abstract] [Full Text] [Related]
6. Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda.
Kirimunda S; Verboom M; Otim I; Ssennono M; Legason ID; Nabalende H; Ogwang MD; Kerchan P; Kinyera T; Mwebaza I; Joloba M; Ayers LW; Reynolds SJ; Bhatia K; Onabajo OO; Hallensleben M; Biggar RJ; Prokunina-Olsson L; Goedert JJ; Blasczyk R; Mbulaiteye SM
Br J Haematol; 2020 May; 189(3):489-499. PubMed ID: 32072624
[TBL] [Abstract] [Full Text] [Related]
7. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R;
Lancet Haematol; 2020 Feb; 7(2):e100-e111. PubMed ID: 31958417
[TBL] [Abstract] [Full Text] [Related]
8. Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer Center.
Linke C; Tragiannidis A; Ahlmann M; Fröhlich B; Wältermann M; Burkhardt B; Rossig C; Groll AH
Mycoses; 2019 Oct; 62(10):954-960. PubMed ID: 31332851
[TBL] [Abstract] [Full Text] [Related]
9. High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party.
Akhtar S; Montoto S; Boumendil A; Finel H; Masszi T; Jindra P; Nemet D; Fuhrmann S; Beguin Y; Castagna L; Ferrara F; Capria S; Malladi R; Moraleda JM; Bloor A; Ghesquières H; Meissner J; Sureda A; Dreger P
Am J Hematol; 2018 Jan; 93(1):40-46. PubMed ID: 28971503
[TBL] [Abstract] [Full Text] [Related]
10. The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia.
Brunstein C; Zhang MJ; Barker J; St Martin A; Bashey A; de Lima M; Dehn J; Hematti P; Perales MA; Rocha V; Territo M; Weisdorf D; Eapen M
Haematologica; 2017 May; 102(5):941-947. PubMed ID: 28126967
[TBL] [Abstract] [Full Text] [Related]
11. Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies.
Jahn L; van der Steen DM; Hagedoorn RS; Hombrink P; Kester MG; Schoonakker MP; de Ridder D; van Veelen PA; Falkenburg JH; Heemskerk MH
Oncotarget; 2016 Nov; 7(47):77021-77037. PubMed ID: 27776339
[TBL] [Abstract] [Full Text] [Related]
12. The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).
Rigacci L; Puccini B; Zinzani PL; Biggi A; Castagnoli A; Merli F; Balzarotti M; Stelitano C; Spina M; Vitolo U; Stefoni V; Levis A; Gotti M; Rosaria S; Maria SP; Bosi A; Gallamini A
Am J Hematol; 2015 Jun; 90(6):499-503. PubMed ID: 25720750
[TBL] [Abstract] [Full Text] [Related]
13. Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus-Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma.
Zheng Y; Parsonage G; Zhuang X; Machado LR; James CH; Salman A; Searle PF; Hui EP; Chan AT; Lee SP
Cancer Immunol Res; 2015 Oct; 3(10):1138-47. PubMed ID: 25711537
[TBL] [Abstract] [Full Text] [Related]
14. Therapeutic targeting of the BCR-associated protein CD79b in a TCR-based approach is hampered by aberrant expression of CD79b.
Jahn L; Hombrink P; Hassan C; Kester MG; van der Steen DM; Hagedoorn RS; Falkenburg JH; van Veelen PA; Heemskerk MH
Blood; 2015 Feb; 125(6):949-58. PubMed ID: 25414443
[TBL] [Abstract] [Full Text] [Related]
15. The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancers.
Oji Y; Tatsumi N; Fukuda M; Nakatsuka S; Aoyagi S; Hirata E; Nanchi I; Fujiki F; Nakajima H; Yamamoto Y; Shibata S; Nakamura M; Hasegawa K; Takagi S; Fukuda I; Hoshikawa T; Murakami Y; Mori M; Inoue M; Naka T; Tomonaga T; Shimizu Y; Nakagawa M; Hasegawa J; Nezu R; Inohara H; Izumoto S; Nonomura N; Yoshimine T; Okumura M; Morii E; Maeda H; Nishida S; Hosen N; Tsuboi A; Oka Y; Sugiyama H
Int J Oncol; 2014 May; 44(5):1461-9. PubMed ID: 24589652
[TBL] [Abstract] [Full Text] [Related]
16. Ceppellini Lecture 2012: collateral damage from HLA mismatching in kidney transplantation.
Opelz G; Döhler B
Tissue Antigens; 2013 Oct; 82(4):235-42. PubMed ID: 24461002
[TBL] [Abstract] [Full Text] [Related]
17. Standard therapies versus novel therapies in Hodgkin lymphoma.
Gallamini A; Di Raimondo F; La Nasa G; Romano A; Borra A; Greco M
Immunol Lett; 2013; 155(1-2):56-9. PubMed ID: 24140162
[TBL] [Abstract] [Full Text] [Related]
18. A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer.
Johung KL; Yao X; Li F; Yu JB; Gettinger SN; Goldberg S; Decker RH; Hess JA; Chiang VL; Contessa JN
Clin Cancer Res; 2013 Oct; 19(19):5523-32. PubMed ID: 23897899
[TBL] [Abstract] [Full Text] [Related]
19. The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis.
Kako S; Morita S; Sakamaki H; Iida H; Kurokawa M; Miyamura K; Kanamori H; Hara M; Kobayashi N; Morishima Y; Kawa K; Kyo T; Sakura T; Jinnai I; Takeuchi J; Miyazaki Y; Miyawaki S; Ohnishi K; Naoe T; Kanda Y
Bone Marrow Transplant; 2013 Aug; 48(8):1077-83. PubMed ID: 23376818
[TBL] [Abstract] [Full Text] [Related]
20. Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.
Nobuoka D; Yoshikawa T; Takahashi M; Iwama T; Horie K; Shimomura M; Suzuki S; Sakemura N; Nakatsugawa M; Sadamori H; Yagi T; Fujiwara T; Nakatsura T
Cancer Immunol Immunother; 2013 Apr; 62(4):639-52. PubMed ID: 23143746
[TBL] [Abstract] [Full Text] [Related]
[Next]
